Guggenheim Capital LLC Novo Cure LTD Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.18 Million - $1.68 Million	106,452 Added 608.4%	123,949 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $5,991 - $15,711	-371 Reduced 2.08%	17,497 $282,000
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $13,376 - $27,393	-332 Reduced 1.82%	17,868 $741,000
Q1 2023 May 10, 2023	SELL	$56.44 - $118.81 $14,222 - $29,940	-252 Reduced 1.37%	18,200 $1.09 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $110,237 - $147,092	-1,723 Reduced 8.54%	18,452 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $212,944 - $280,533	3,132 Added 18.38%	20,175 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $148,801 - $236,347	2,629 Added 18.24%	17,043 $1.18 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $867,002 - $1.22 Million	14,414 New	14,414 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $2.08 Million - $3.37 Million	-27,658 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $1.37 Million - $2.29 Million	11,781 Added 74.2%	27,658 $3.21 Million
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $1.13 Million - $1.96 Million	-8,670 Reduced 35.32%	15,877 $3.52 Million
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $286,694 - $439,292	2,310 Added 10.39%	24,547 $3.25 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $245,069 - $380,495	-2,185 Reduced 8.95%	22,237 $3.85 Million
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $2.44 Million - $4.68 Million	-42,079 Reduced 63.28%	24,422 $2.72 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $3.8 Million - $4.95 Million	66,501 New	66,501 $3.94 Million
Q1 2020 Jun 02, 2020	SELL	$57.05 - $95.75 $261,973 - $439,684	-4,592 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $313,633 - $430,729	4,592 New	4,592 $387,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $127,918 - $234,414	-4,454 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $142,528 - $233,389	4,454 New	4,454 $233,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

76.9M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$318 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$310 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$207 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$113 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$79.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.75B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account